Cargando…
Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes
The vascular endothelium, the largest “organ” in the body, synthesizes and releases a wide spectrum of vasoactive substances into the circulation. Endothelial dysfunction links hypertension and other cardiovascular (CV) risk factors that promote the development of atherosclerotic plaque, CV disease,...
Autores principales: | Pimenta, Eduardo, Oparil, Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172062/ https://www.ncbi.nlm.nih.gov/pubmed/21949627 http://dx.doi.org/10.2147/IBPC.S11717 |
Ejemplares similares
-
Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination
por: Pimenta, Eduardo, et al.
Publicado: (2008) -
Role of olmesartan in combination therapy in blood pressure control and vascular function
por: Ferrario, Carlos M, et al.
Publicado: (2010) -
Olmesartan/Amlodipine/Hydrochlorothiazide in Obese Participants With Hypertension: A TRINITY Subanalysis
por: Roth, Eli M., et al.
Publicado: (2013) -
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009) -
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
por: Pimenta, Eduardo, et al.
Publicado: (2009)